Health care providers using a device from Abbott Laboratories to stop heart valve leakage should be on the lookout for a malfunction that can lead to heart attack, stroke, or death.
The Food and Drug Administration issued a
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?